Ultralife Corp. (NASDAQ:ULBI) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 143,000 shares, a growth of 5.1% from the December 15th total of 136,100 shares. Based on an average daily trading volume, of 19,300 shares, the days-to-cover ratio is presently 7.4 days. Approximately 1.4% of the shares of the stock are sold short.

Several large investors have recently modified their holdings of the company. Marshall Wace North America L.P. acquired a new position in shares of Ultralife in the 1st quarter valued at approximately $36,000. Wells Fargo & Company MN acquired a new position in shares of Ultralife in the 2nd quarter valued at approximately $54,000. Ancora Advisors LLC raised its position in shares of Ultralife by 13.1% in the 3rd quarter. Ancora Advisors LLC now owns 60,225 shares of the technology company’s stock valued at $522,000 after buying an additional 6,960 shares in the last quarter. Teton Advisors Inc. raised its position in shares of Ultralife by 12.7% in the 3rd quarter. Teton Advisors Inc. now owns 142,200 shares of the technology company’s stock valued at $1,231,000 after buying an additional 16,000 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Ultralife by 3.7% in the 2nd quarter. Vanguard Group Inc. now owns 511,044 shares of the technology company’s stock valued at $4,063,000 after buying an additional 18,169 shares in the last quarter. Institutional investors own 32.99% of the company’s stock.

Shares of NASDAQ:ULBI opened at $7.28 on Thursday. The firm has a 50 day moving average of $7.67 and a 200-day moving average of $8.33. The stock has a market capitalization of $114.49 million, a PE ratio of 4.85 and a beta of 0.86. The company has a current ratio of 3.78, a quick ratio of 2.00 and a debt-to-equity ratio of 0.15. Ultralife has a 12 month low of $6.99 and a 12 month high of $11.97.

Ultralife (NASDAQ:ULBI) last issued its earnings results on Thursday, October 31st. The technology company reported $0.07 EPS for the quarter. The company had revenue of $27.49 million during the quarter. Ultralife had a net margin of 24.12% and a return on equity of 22.91%.

Separately, ValuEngine upgraded shares of Ultralife from a “hold” rating to a “buy” rating in a research report on Friday, January 10th.

Ultralife Company Profile

Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Article: Why is the ex-dividend date different from the record date?

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.